Less Use of NSAIDs in Long-Term than in Recent Chondroitin Sulphate Users in Osteoarthritis: a Pharmacy-based Observational Study in France
Thérapie, 61 4 (2006) 341-346
Publié en ligne : 2007-02-07
Article cité par
La fonctionnalité Article cité par… liste les citations d'un article. Ces citations proviennent de la base de données des articles de EDP Sciences, ainsi que des bases de données d'autres éditeurs participant au programme CrossRef Cited-by Linking Program. Vous pouvez définir une alerte courriel pour être prévenu de la parution d'un nouvel article citant " cet article (voir sur la page du résumé de l'article le menu à droite).
Article cité :
Citations de cet article :
Highly purified chondroitin sulfate: a literature review on clinical efficacy and pharmacoeconomic aspects in osteoarthritis treatment
Jean-Yves Reginster and Nicola VeroneseAging Clinical and Experimental Research 33 (1) 37 (2021)
https://doi.org/10.1007/s40520-020-01643-8
Access to Highly Purified Chondroitin Sulfate for Appropriate Treatment of Osteoarthritis: A Review
Xavier Chevalier and Thierry ConrozierMedicine Access @ Point of Care 1 (2017)
https://doi.org/10.5301/maapoc.0000022
Effects of glucosamine sulfate on the use of rescue non-steroidal anti-inflammatory drugs in knee osteoarthritis: Results from the Pharmaco-Epidemiology of GonArthroSis (PEGASus) study
Lucio C. Rovati, Federica Girolami, Massimo D’Amato and Giampaolo GiacovelliSeminars in Arthritis and Rheumatism 45 (4) S34 (2016)
https://doi.org/10.1016/j.semarthrit.2015.10.009
Discriminant Capacity of Clinical Efficacy and Nonsteroidal Antiinflammatory Drug-sparing Endpoints, Alone or in Combination, in Axial Spondyloarthritis
Maxime Dougados, Emily Wood, Laure Gossec, et al.The Journal of Rheumatology 42 (12) 2361 (2015)
https://doi.org/10.3899/jrheum.150378
An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: A report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)
Olivier Bruyère, Cyrus Cooper, Jean-Pierre Pelletier, Jaime Branco, Maria Luisa Brandi, Francis Guillemin, Marc C. Hochberg, John A. Kanis, Tore K. Kvien, Johanne Martel-Pelletier, René Rizzoli, Stuart Silverman and Jean-Yves ReginsterSeminars in Arthritis and Rheumatism 44 (3) 253 (2014)
https://doi.org/10.1016/j.semarthrit.2014.05.014
What is the current status of chondroitin sulfate and glucosamine for the treatment of knee osteoarthritis?
Yves Henrotin, Marc Marty and Ali MobasheriMaturitas 78 (3) 184 (2014)
https://doi.org/10.1016/j.maturitas.2014.04.015
Evaluación económica del uso de condroitín sulfato y antiinflamatorios no esteroideos en el tratamiento de la artrosis. Datos del estudio VECTRA
Carlos Rubio-TerrésReumatología Clínica 6 (4) 187 (2010)
https://doi.org/10.1016/j.reuma.2009.12.009
An economic evaluation of chondroitin sulfate and non-steroidal anti-inflammatory drugs for the treatment of osteoarthritis. Data from the VECTRA study
Carlos Rubio-TerrésReumatología Clínica (English Edition) 6 (4) 187 (2010)
https://doi.org/10.1016/S2173-5743(10)70043-5
Phytalgic®, a food supplement, vs placebo in patients with osteoarthritis of the knee or hip: a randomised double-blind placebo-controlled clinical trial
Alain Jacquet, Pierre-Olivier Girodet, Antoine Pariente, Karelle Forest, Laurent Mallet and Nicholas MooreArthritis Research & Therapy 11 (6) (2009)
https://doi.org/10.1186/ar2891
Importance of pharmaceutical composition and evidence from clinical trials and pharmacological studies in determining effectiveness of chondroitin sulphate and other glycosaminoglycans: a critique
K D RainsfordJournal of Pharmacy and Pharmacology 61 (10) 1263 (2009)
https://doi.org/10.1211/jpp.61.10.0001